Terms ending in 2037
Every in-force patent on Merck & Cie's record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,059,710 | Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid In force · High confidence | Merck & Cie | In force | High confidence | |
| US 10,336,758 | New stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid In force · High confidence | Merck & Cie | In force | High confidence | |
| US 10,570,134 | Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid In force · High confidence | Merck & Cie | In force | High confidence | |
| US 11,306,094 | Stable Formulations of 5,10-Methylene-(6R)-TETRAHYDROFOLIC Acid In force · High confidence | Merck & Cie | In force | High confidence | |
| US 12,103,930 | Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid In force · High confidence | Merck & Cie | In force | High confidence |
5 of 5 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.